Treatment and recurrence on re-treatment tuberculosis patients: a randomized clinical trial and 7-year perspective cohort study in China
Jian Du(Capital Medical University), Zhongwei Jia(Peking University), Qiping Ge(Capital Medical University), Yan Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), X. Tian(Capital Medical University), Le Zhang(Karolinska Institutet), Weiwei Gao(Capital Medical University), X.-Y. Chen(Capital Medical University)
European Journal of Clinical Microbiology & Infectious Diseases
December 5, 2019
Cited by 12
Related Papers
Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases
|JAMA Psychiatry|2023|128
Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram
|Patient Preference and Adherence|2018|111
Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis
|Clinical Gastroenterology and Hepatology|2019|95
NRAMP1, VDR, HLA-DRB1, and HLA-DQB1 Gene Polymorphisms in Susceptibility to Tuberculosis among the Chinese Kazakh Population: A Case-Control Study
|BioMed Research International|2013|62